Fagerström Test for Nicotine Dependence

The Fagerström Test for Nicotine Dependence (FTND) is a widely recognized, validated clinical instrument designed to assess the intensity of physical addiction to nicotine. Originally introduced as a revision of the Fagerström Tolerance Questionnaire, this concise six-item measure provides mental health and primary care professionals with a standardized way to quantify a patient's physiological reliance on cigarettes.

Rather than relying purely on patient self-report of feeling dependent, the FTND zeroes in on observable markers of addiction, such as morning use patterns and behavioral rigidity. This helps clinicians build a more accurate picture when building discrepancy around a patient's motivation to quit.

By yielding a numerical score, the instrument helps identify individuals likely to experience severe withdrawal symptoms. It serves as a practical decision-making aid, particularly when evaluating whether the patient might benefit from pharmacological support alongside behavioral strategies for building new habits as they work toward sustained abstinence.

The FTND measures the severity of physical nicotine dependence through observable behavioral indicators of physiological need and tolerance.

• Urgency of consumption: The time elapsed between waking and smoking the first cigarette, which serves as a proxy for overnight withdrawal severity.
• Compulsion to use: The difficulty of refraining from smoking in prohibited environments, highlighting the inflexibility of automatic behaviors tied to addiction.
• Prioritization of intake: The subjective value placed on specific cigarettes, particularly the highly reinforced first morning dose.
• Volume of consumption: The average daily quantity of cigarettes smoked, indicating the baseline level of physiological tolerance.
• Circadian distribution: The clustering of smoking behavior in the early hours to replenish depleted nicotine levels.
• Persistence during illness: The continuation of smoking despite severe physical illness, illustrating when substance use overshadows adaptive coping and basic self-care.

This instrument is intended for use with adult and adolescent patients who currently smoke cigarettes.

Clinicians typically administer the FTND during the initial assessment of a patient presenting with tobacco use, or when structuring a comprehensive cessation intervention.

• Intake assessment: To establish a standardized baseline of physical addiction before addressing the psychological function of smoking.
• Treatment planning: To orient the clinical decision regarding the necessity of nicotine replacement therapy (NRT) or other pharmacological aids.
• Monitoring change: To review progress during a structured weekly behavioral review if the cessation plan involves gradual reduction.
• Relapse analysis: To better understand the physiological drivers behind past unsuccessful quit attempts and adjust future interventions accordingly.

Using a validated measure like the FTND provides a concrete severity metric that complements clinical interviewing, ensuring the physiological dimensions of addiction are accurately weighted when discussing the patient's medium- and long-term goals for their health.